BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 10411484)

  • 21. QSAR study on carbonic anhydrase inhibitors: water-soluble sulfonamides incorporating beta-alanyl moieties, possessing long lasting-intra ocular pressure lowering properties--a molecular connectivity approach.
    Agrawal VK; Banerji M; Gupta M; Singh J; Khadikar PV; Supuran CT
    Eur J Med Chem; 2005 Oct; 40(10):1002-12. PubMed ID: 15961191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbonic anhydrase inhibitors: topical sulfonamide antiglaucoma agents incorporating secondary amine moieties.
    Renzi G; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2000 Apr; 10(7):673-6. PubMed ID: 10762051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives.
    Innocenti A; Antel J; Wurl M; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5703-7. PubMed ID: 15482952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbonic anhydrase inhibitors with strong topical antiglaucoma properties incorporating a 4-(2-aminopyrimidin-4-yl-amino)-benzenesulfonamide scaffold.
    Casini A; Mincione F; Vullo D; Menabuoni L; Scozzafava A; Supuran CT
    J Enzyme Inhib Med Chem; 2002 Feb; 17(1):9-18. PubMed ID: 12365464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QSAR study on carbonic anhydrase inhibitors: aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties, with topical activity as antiglaucoma agents.
    Agrawal VK; Bano S; Supuran CT; Khadikar PV
    Eur J Med Chem; 2004 Jul; 39(7):593-600. PubMed ID: 15236839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbonic anhydrase inhibitors: synthesis of water soluble sulfonamides incorporating a 4-sulfamoylphenylmethylthiourea scaffold, with potent intraocular pressure lowering properties.
    Casini A; Scozzafava A; Mincione F; Menabuoni L; Supuran CT
    J Enzyme Inhib Med Chem; 2002 Oct; 17(5):333-43. PubMed ID: 12683750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
    Brechue WF; Maren TH
    Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design.
    Lehtonen JM; Parkkila S; Vullo D; Casini A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3757-62. PubMed ID: 15203157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamides.
    Ozensoy O; Nishimori I; Vullo D; Puccetti L; Scozzafava A; Supuran CT
    Bioorg Med Chem; 2005 Nov; 13(22):6089-93. PubMed ID: 16006130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties.
    Scozzafava A; Menabuoni L; Mincione F; Supuran CT
    J Med Chem; 2002 Mar; 45(7):1466-76. PubMed ID: 11906288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbonic anhydrase inhibitors: aromatic and heterocyclic sulfonamides incorporating adamantyl moieties with strong anticonvulsant activity.
    Ilies MA; Masereel B; Rolin S; Scozzafava A; Câmpeanu G; Cîmpeanu V; Supuran CT
    Bioorg Med Chem; 2004 May; 12(10):2717-26. PubMed ID: 15110853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbonic anhydrase inhibitors: novel compounds containing S-NH moieties: sulfenamido-sulfonamides, sulfenimido-sulfonamides and their interaction with isozymes I, II and IV.
    Scozzafava A; Supuran CT
    J Enzyme Inhib; 1998 Sep; 13(6):419-42. PubMed ID: 9825306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
    Bioorg Med Chem; 2009 Jul; 17(14):4894-9. PubMed ID: 19539481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Szafrański K; Vullo D; Supuran CT
    Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with a topically acting antiglaucoma sulfonamide.
    Abbate F; Casini A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 May; 14(9):2357-61. PubMed ID: 15081040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbonic anhydrase inhibitors: 4-sulfamoyl-benzenecarboxamides and 4-chloro-3-sulfamoyl-benzenecarboxamides with strong topical antiglaucoma properties.
    Mincione F; Starnotti M; Menabuoni L; Scozzafava A; Casini A; Supuran CT
    Bioorg Med Chem Lett; 2001 Jul; 11(13):1787-91. PubMed ID: 11425561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclodextrin complexes of sulfonamide carbonic anhydrase inhibitors as long-lasting topically acting antiglaucoma agents.
    Maestrelli F; Mura P; Casini A; Mincione F; Scozzafava A; Supuran CT
    J Pharm Sci; 2002 Oct; 91(10):2211-9. PubMed ID: 12226848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3170-3. PubMed ID: 19435663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbonic anhydrase inhibitors: inhibition of cytosolic/tumor-associated isoforms I, II, and IX with iminodiacetic carboxylates/hydroxamates also incorporating benzenesulfonamide moieties.
    Santos MA; Marques S; Vullo D; Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1538-43. PubMed ID: 17251018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbonic anhydrase inhibitory activity and ocular pharmacology of organic sulfamates.
    Brechue WF; Maren TH
    J Pharmacol Exp Ther; 1993 Feb; 264(2):670-5. PubMed ID: 8437114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.